Blood Proteins May Reveal Who Benefits Most From Lung Cancer Immunotherapy
Immunotherapy has transformed the treatment of advanced non-small cell lung cancer, turning a disease that once carried a uniformly grim prognosis into one where a meaningful fraction of patients can achieve durable disease control. Yet oncologists have …